149 related articles for article (PubMed ID: 38364104)
1. Early antiretroviral therapy and its impact on natural killer cell dynamics in HIV-1 infected men who have sex with men: a cross-sectional pilot study evaluating the impact of early ART initiation on NK cell perturbation in HIV infection.
Akiso M; Muema D; Langat R; Naidoo KK; Oino G; Mutua G; Thobakgale C; Ochiel D; Chinyenze K; Anzala O; Mureithi MW
Microbiol Spectr; 2024 Apr; 12(4):e0357023. PubMed ID: 38364104
[TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells.
Porichis F; Hart MG; Massa A; Everett HL; Morou A; Richard J; Brassard N; Veillette M; Hassan M; Ly NL; Routy JP; Freeman GJ; Dubé M; Finzi A; Kaufmann DE
J Immunol; 2018 Aug; 201(3):971-981. PubMed ID: 29934472
[TBL] [Abstract][Full Text] [Related]
3. Antigen Presenting Cells Contribute to Persistent Immune Activation Despite Antiretroviral Therapy Initiation During Hyperacute HIV-1 Infection.
Naidoo KK; Ndumnego OC; Ismail N; Dong KL; Ndung'u T
Front Immunol; 2021; 12():738743. PubMed ID: 34630420
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Bender Ignacio RA; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N;
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 35544209
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study.
Massanella M; Ignacio RAB; Lama JR; Pagliuzza A; Dasgupta S; Alfaro R; Rios J; Ganoza C; Pinto-Santini D; Gilada T; Duerr A; Chomont N
Lancet Microbe; 2021 May; 2(5):e198-e209. PubMed ID: 34841369
[TBL] [Abstract][Full Text] [Related]
6. Timing of Antiretroviral Therapy Initiation Determines Rectal Natural Killer Cell Populations.
Utay NS; Vigil KJ; Somasunderam A; Aulicino PC; Smulevitz B; Chiadika S; Wolf DS; Kimata JT; Arduino RC
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):314-323. PubMed ID: 31838858
[TBL] [Abstract][Full Text] [Related]
7. HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.
Papasavvas E; Azzoni L; Yin X; Liu Q; Joseph J; Mackiewicz A; Ross B; Lynn KM; Jacobson JM; Mounzer K; Kostman JR; Montaner LJ
J Viral Hepat; 2017 Oct; 24(10):865-876. PubMed ID: 28419653
[TBL] [Abstract][Full Text] [Related]
8. Adaptive NK Cells Rapidly Expand during Acute HIV Infection and Persist Despite Early Initiation of Antiretroviral Therapy.
Hearps AC; Zhou J; Agius PA; Ha P; Lee S; Price P; Kek H; Kroon E; Akapirat S; Pinyakorn S; Phanuphak N; Sacdalan C; Hsu D; Ananworanich J; Vasan S; Schuetz A; Jaworowski A;
J Immunol; 2024 May; 212(10):1553-1563. PubMed ID: 38558245
[TBL] [Abstract][Full Text] [Related]
9. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
10. Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort).
Doria M; Zicari S; Cotugno N; Domínguez-Rodríguez S; Ruggiero A; Pascucci GR; Tagarro A; Rojo Conejo P; Nastouli E; Gärtner K; Cameron M; Richardson B; Foster C; Williams SL; Rinaldi S; De Rossi A; Giaquinto C; Rossi P; Pahwa S; Palma P;
J Int AIDS Soc; 2021 Jul; 24(7):e25717. PubMed ID: 34235857
[TBL] [Abstract][Full Text] [Related]
11. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
[TBL] [Abstract][Full Text] [Related]
12. Identification of NK Cell Subpopulations That Differentiate HIV-Infected Subject Cohorts with Diverse Levels of Virus Control.
Pohlmeyer CW; Gonzalez VD; Irrinki A; Ramirez RN; Li L; Mulato A; Murry JP; Arvey A; Hoh R; Deeks SG; Kukolj G; Cihlar T; Pflanz S; Nolan GP; Min-Oo G
J Virol; 2019 Apr; 93(7):. PubMed ID: 30700608
[TBL] [Abstract][Full Text] [Related]
13. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
14. IL-10
Jiang Y; Yang M; Sun X; Chen X; Ma M; Yin X; Qian S; Zhang Z; Fu Y; Liu J; Han X; Xu J; Shang H
BMC Infect Dis; 2018 Feb; 18(1):80. PubMed ID: 29439673
[TBL] [Abstract][Full Text] [Related]
15. Increased Natural Killer Cell Activation in HIV-Infected Immunologic Non-Responders Correlates with CD4+ T Cell Recovery after Antiretroviral Therapy and Viral Suppression.
Luo Z; Li Z; Martin L; Hu Z; Wu H; Wan Z; Kilby M; Heath SL; Huang L; Jiang W
PLoS One; 2017; 12(1):e0167640. PubMed ID: 28076376
[TBL] [Abstract][Full Text] [Related]
16. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
[TBL] [Abstract][Full Text] [Related]
17. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
[TBL] [Abstract][Full Text] [Related]
18. Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults.
Wong AH; Williams K; Reddy S; Wilson D; Giddy J; Alter G; Ghebremichael M; Carrington MN; Ndung'u T; Walker BD; Altfeld M; Carr WH
AIDS Res Hum Retroviruses; 2010 Apr; 26(4):459-69. PubMed ID: 20380481
[TBL] [Abstract][Full Text] [Related]
19. Impact of antiretroviral therapy in primary HIV infection on natural killer cell function and the association with viral rebound and HIV DNA following treatment interruption.
Pace M; Ogbe A; Hurst J; Robinson N; Meyerowitz J; Olejniczak N; Thornhill JP; Jones M; Waters A; Lwanga J; Kuldanek K; Hall R; Zacharopoulou P; Martin GE; Brown H; Nwokolo N; Peppa D; Fox J; Fidler S; Frater J
Front Immunol; 2022; 13():878743. PubMed ID: 36110857
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events.
Woolley G; Mosher M; Kroll K; Jones R; Hueber B; Sugawara S; Manickam C; Terry K; Varner V; Lifton M; Ram D; Fennessey CM; Keele BF; Reeves RK
J Virol; 2023 Jan; 97(1):e0151922. PubMed ID: 36511699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]